EU Drug Supply In Jeopardy Without Energy Support, Warns Medicines For Europe
Industry Body Raises The Alarm Over Energy Costs In Open Letter
Medicines for Europe calls for the pharmaceutical industry to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. Inflation and energy costs threaten European drug makers with closures and rationing, says the industry body.
